David S. Mathai
Impact in
- Biological Psychiatry top 5%
- Tryptophan and brain disorders
- Pharmacology top 10%
- Treatment of Major Depression
- Cannabis and Cannabinoid Research
Papers in
-
- Psychedelics and Drug Studies 9
- Child and Adolescent Psychosocial and Emotional Development 4
- Pharmacology 13
- Treatment of Major Depression 7
- Cannabis and Cannabinoid Research 6
- Co-authors
- Albert Garcia‐Romeu (8 shared papers)Eric A. Storch (7 shared papers)Thomas R. Kosten (3 shared papers)Matthew J. Meyer (1 shared paper)Sandeep M. Nayak (4 shared papers)David B. Yaden (2 shared papers)Noel Fidge (1 shared paper)Minoru Tozuka (1 shared paper)
- Journals
- Journal of Affective Disorders (4 papers)Scientific Reports (1 paper)Frontiers in Psychiatry (1 paper)Journal of Child and Adolescent Psychopharmacology (1 paper)Expert Review of Neurotherapeutics (1 paper)
- Partner nations
- United StatesAustraliaUnited Kingdom
In The Last Decade
David S. Mathai
22 papers receiving 256 citations
Peers
Comparison fields: 5 of 45
- Biological Psychiatry 87
- Pharmacology 134
- Clinical Psychology 162
- Cellular and Molecular Neuroscience 64
- Organic Chemistry 64
Countries citing papers authored by David S. Mathai
This map shows the geographic impact of David S. Mathai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David S. Mathai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David S. Mathai more than expected).
Fields of papers citing papers by David S. Mathai
This network shows the impact of papers produced by David S. Mathai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David S. Mathai. The network helps show where David S. Mathai may publish in the future.
Co-authors
The 25 scholars most cited alongside David S. Mathai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 63 | |
| 2 | 2023 | 45 | |
| 3 | 2022 | 28 | |
| 4 | 2023 | 25 | |
| 5 | 1990 | 17 | |
| 6 | 2022 | 13 | |
| 7 | 2021 | 12 | |
| 8 | 2022 | 9 | |
| 9 | 2024 | 7 | |
| 10 | 2020 | 7 | |
| 11 | 2024 | 7 | |
| 12 | 2017 | 7 | |
| 13 | 2023 | 5 | |
| 14 | 2019 | 5 | |
| 15 | 2022 | 4 | |
| 16 | 2025 | 3 | |
| 17 | 2019 | 3 | |
| 18 | 2021 | 1 | |
| 19 | 2024 | 1 | |
| 20 | 2024 | 1 |
About David S. Mathai
David S. Mathai is a scholar working on Clinical Psychology, Pharmacology, Biological Psychiatry, Psychiatry and Mental health and Organic Chemistry, having authored 23 papers that have together received 265 indexed citations. Recurring topics across this work include Psychedelics and Drug Studies (9 papers), Treatment of Major Depression (7 papers), Tryptophan and brain disorders (6 papers), Cannabis and Cannabinoid Research (6 papers), Child and Adolescent Psychosocial and Emotional Development (4 papers), Chemical synthesis and alkaloids (4 papers), Bipolar Disorder and Treatment (3 papers) and Complementary and Alternative Medicine Studies (3 papers). The work is most often cited by research in Biological Psychiatry (87 citations), Pharmacology (134 citations), Clinical Psychology (162 citations), Cellular and Molecular Neuroscience (64 citations) and Organic Chemistry (64 citations). David S. Mathai has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Albert Garcia‐Romeu, Eric A. Storch, Thomas R. Kosten, Matthew J. Meyer, Sandeep M. Nayak, David B. Yaden, Noel Fidge, Minoru Tozuka, Nathan D. Sepeda and Justin C. Strickland. Their work appears in journals such as Journal of Affective Disorders, Scientific Reports, Frontiers in Psychiatry, Journal of Child and Adolescent Psychopharmacology and Expert Review of Neurotherapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.